Evidence map›Paper›PMID 23423314›Full record

ArticleThe American journal of sports medicine2013

Relationship between markers of type II collagen metabolism and tibiofemoral joint space width changes after ACL injury and reconstruction.

Timothy W Tourville, Robert J Johnson, James R Slauterbeck, Shelly Naud, Bruce D Beynnon

Open access · greenAbstract read
In one paragraph

Article in The American journal of sports medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Distinct patterns of cytokines, chemokines, and growth factors in synovial fluid after ACL injury in comparison to osteoarthritis.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Biochemical markers of cartilage metabolism are associated with walking biomechanics 6-months following anterior cruciate ligament reconstruction.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2017
    Article
  13. Article
  14. Article
  15. Relationship between synovial fluid ARGS-aggrecan fragments, cytokines, MMPs, and TIMPs following acute ACL injury: A cross-sectional study.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2015
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Timothy W TourvilleDepartment of Orthopaedics and Rehabilitation, University of Vermont College of Medicine, Burlington, VT 05405, USA.
Robert J Johnson
James R Slauterbeck
Shelly Naud
Bruce D Beynnon
University of Vermont · USUniversity of Vermont Medical Center · US

Funding

Biomarkers of Cartilage Metabolism and OAR01AR051477 · NIAMS · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI BEYNNON, BRUCE · 2004 to 2008
$1.7M
NIAMS NIH HHS R01 AR051477NIAMS NIH HHS R01 AR051477-01
6 · The paper itself

Abstract

backgroundThose who suffer anterior cruciate ligament (ACL) disruptions are at increased risk of experiencing posttraumatic osteoarthritis (OA); however, by the time they become symptomatic, irreversible damage has likely occurred. Little is known regarding the physiological changes in articular cartilage that occur after an ACL injury and the onset of OA. PURPOSE: To assess whether patient, functional, and clinical outcomes and type II collagen metabolism are associated with abnormal tibiofemoral joint space width (JSW) 4 years after injury and reconstruction. STUDY

designCohort study; Level of evidence, 2.

methodsA total of 35 ACL-injured patients who underwent ACL reconstruction were enrolled soon after injury, as were 32 matched controls. At baseline and 1- and 4-year follow-ups, patient-oriented subjective and objective outcomes and markers of type II collagen metabolism (considered as the ratio of cleavage to synthesis of type II collagen) were evaluated, as were radiographic measurements of JSW changes about the medial and lateral compartments of the knee. ACL-injured patients were divided into normal and abnormal JSW groups.

resultsBoth ACL-injured groups (normal and abnormal JSW) had an increased ratio of collagen type I and II cleavage product (uC1,2C) to serum procollagen II C-propeptide (sCPII) compared with controls at 1- and 4-year follow-ups. Patients in the ACL group with an abnormal JSW difference had significantly increased cleavage-to-synthesis ratios of type II collagen (assessed as C-terminal cross-linked telopeptide of type II collagen [uCTX-II]/sCPII ratio) compared with controls at 4-year follow-up. ACL-injured patients with an abnormal JSW difference had significantly increased pain and decreased quality of life (Knee Injury and Osteoarthritis Outcome Score [KOOS]) scores than did ACL-injured patients with a normal JSW difference.

conclusionACL-injured patients with an abnormal tibiofemoral JSW had diminished quality of life, increased pain, and increased type II collagen uCTX-II/sCPII ratios compared with healthy controls. These changes occurred over an interval shortly after injury in patients who were fully functional and who had normal clinical examination findings, no pivoting/giving-way episodes, and no decrease in activity level.

Indexed as

AdolescentAdultAnterior Cruciate Ligament InjuriesAnterior Cruciate Ligament ReconstructionBiomarkersBone-Patellar Tendon-Bone GraftingCartilage, ArticularCase-Control StudiesCollagen Type IIFemaleHumansKnee InjuriesKnee JointLongitudinal StudiesMaleMiddle AgedBiomarkersCollagen Type II

Identifiers

PMID23423314
PMCPMC6503972
OpenAlexW2105661835

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.